An immune-suppressive tumor environment constituted by Tregs and M2 macrophages along with immunosuppressive mediators such as CCL17, CCL18, CCL22, and PD-L1 can assist tumor development and progression (20, 21). The gene discussed is CCL17; the disease is neoplasm.